Gustavo Dziewczapolski

Scientific Director, Cure CMD

Gustavo  Dziewczapolski

Dr. Dziewczapolski received his Master's degree from the University of Buenos Aires, followed by a Ph.D. in Neuropharmacology. He then moved to the United States to hone his scientific career in neurosciences, spanning eighteen years in research at UC San Diego and the Salk Institute. Dr. Dziewczapolski joined Cure CMD, an Advocacy Patient Organization, as the new Scientific Director on September 1st 2016. He plays the role of liaison between researchers, clinicians, pharma industry, patients and families with the aim of accelerating CMD research, diagnostics, care standards, and translation of research discoveries into real therapies.